Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer K Brachmann

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|July 29, 2004
p53 mutants: the achilles' heel of human cancers?Rainer K Brachmann
Cancer Biology & Therapy|December 7, 2007
hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-cateninMin Yang, Marian L Waterman, Rainer K Brachmann
Cancer Informatics|May 22, 2009
Heterogeneous biomedical database integration using a hybrid strategy: a p53 cancer research databaseVadim Y Bichutskiy, Richard Colman, Rainer K Brachmann, et al.
Oncogene|November 7, 2002
Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sitesHua Qian, Ting Wang, Louie Naumovski, et al.
Bioinformatics (Oxford, England)|July 25, 2007
Choosing where to look next in a mutation sequence space: Active Learning of informative p53 cancer rescue mutantsSamuel A Danziger, Jue Zeng, Ying Wang, et al.
Carcinogenesis|July 25, 2006
Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancersLawrence R Dearth, Hua Qian, Ting Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53Ting Wang, Jue Zeng, Craig B Lowe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2004
A global suppressor motif for p53 cancer mutantsTimothy E Baroni, Ting Wang, Hua Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2017
A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid TumorsAntonio Jimeno, Michael Gordon, Rashmi Chugh, et al.
Nucleic Acids Research|December 19, 2007
Genome wide screens in yeast to identify potential binding sites and target genes of DNA-binding proteinsJue Zeng, Jizhou Yan, Ting Wang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|July 29, 2004
p53 mutants: the achilles' heel of human cancers?Rainer K Brachmann
Cancer Biology & Therapy|December 7, 2007
hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-cateninMin Yang, Marian L Waterman, Rainer K Brachmann
Cancer Informatics|May 22, 2009
Heterogeneous biomedical database integration using a hybrid strategy: a p53 cancer research databaseVadim Y Bichutskiy, Richard Colman, Rainer K Brachmann, et al.
Oncogene|November 7, 2002
Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sitesHua Qian, Ting Wang, Louie Naumovski, et al.
Bioinformatics (Oxford, England)|July 25, 2007
Choosing where to look next in a mutation sequence space: Active Learning of informative p53 cancer rescue mutantsSamuel A Danziger, Jue Zeng, Ying Wang, et al.
Carcinogenesis|July 25, 2006
Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancersLawrence R Dearth, Hua Qian, Ting Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53Ting Wang, Jue Zeng, Craig B Lowe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2004
A global suppressor motif for p53 cancer mutantsTimothy E Baroni, Ting Wang, Hua Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2017
A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid TumorsAntonio Jimeno, Michael Gordon, Rashmi Chugh, et al.
Nucleic Acids Research|December 19, 2007
Genome wide screens in yeast to identify potential binding sites and target genes of DNA-binding proteinsJue Zeng, Jizhou Yan, Ting Wang, et al.
Pageof 2